Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

Publisher： John Wiley & Sons Inc

E-ISSN： 1601-0825|1354-523X|7|899-904

ISSN： 1354-523x

Source： ORAL DISEASES, Vol.1354-523X, Iss.7, 2015-10, pp. : 899-904

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma

By  

ORAL DISEASES, Vol. 21, Iss. 7, 2015-10 ,pp. : 899-904

John Wiley & Sons Inc

Access to resources Recommend Favorite

Oral cavity and oropharyngeal squamous cell carcinoma—an update

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 5, 2015-09 ,pp. : 401-421

John Wiley & Sons Inc

Access to resources Recommend Favorite

ANGPTL4 regulates the metastatic potential of oral squamous cell carcinoma

By  

JOURNAL OF ORAL PATHOLOGY & MEDICINE, Vol. 44, Iss. 2, 2015-02 ,pp. : 126-133

John Wiley & Sons Inc

Access to resources Recommend Favorite

Frequent loss of inositol polyphosphate‐5‐phosphatase in oropharyngeal squamous cell carcinoma

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 32, Iss. 1, 2018-01 ,pp. : e36-e37

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subacute cutaneous lupus erythematosus: a paraneoplastic phenomenon in oropharyngeal squamous cell carcinoma

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 3, 2015-04 ,pp. : 335-337

John Wiley & Sons Inc

Access to resources Recommend Favorite